BioSpace News Archive

Business

Zepp Health Corp. to Report Fourth Quarter and Full Year 2021 Financial Results on March 17, 2022

Zepp Health Corp. today announced that it will report its fourth quarter and full year 2021 unaudited financial results.

March 1, 2022
·
2 min read
Pharm Country

PLx Pharma Inc. to Present at Oppenheimer & Co’s 32nd Annual Healthcare Conference on March 15, 2022

PLx Pharma Inc. today announced that Natasha Giordano, President and CEO of PLx Pharma Inc. and Rita O’Connor, Chief Financial Officer & Head of Manufacturing & Supply Chain, will present on March 15, 2022, at Oppenheimer & Co’s 32nd Annual Healthcare Conference, which will be a virtual event this year.

March 1, 2022
·
2 min read
Genetown

Akouos to Present at Cowen 42nd Annual Heath Care Conference

Akouos, Inc. announced that Manny Simons, Ph.D., M.B.A., co-founder, president, and chief executive officer of Akouos, will participate in a panel discussion titled Auditory and Ophthalmology at the Cowen 42nd Annual Health Care Conference on Monday, March 7 at 2:10 p.m. EST.

March 1, 2022
·
1 min read
IDT Biologika collaborates with Exothera to push forward the scale-up of viral vaccines

IDT Biologika, a leading Contract Development and Manufacturing Organization specialized in vaccines, gene and immune therapy and oncolytic viruses based in Germany, and Exothera S.A. collaborate to develop a large-scale manufacturing process for viral vector-based vaccines.

March 1, 2022
·
2 min read
Bio NC

United Therapeutics Corporation to Present at the Cowen 42nd Annual Health Care Conference

The session will take place virtually on Tuesday, March 8, 2022, from 11:10 a.m. to 11:40 a.m., Eastern Standard Time, and can be accessed via a live webcast on the United Therapeutics website at https://ir.unither.com/events-and-presentations.

March 1, 2022
·
3 min read
Business

Xilio Therapeutics Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results

Xilio Therapeutics, Inc. today announced pipeline and business progress and reported financial results for the fourth quarter and full year ended December 31, 2021.

March 1, 2022
·
9 min read
Business

Caris’ Precision Oncology Alliance Welcomes Tampa General Hospital Cancer Institute

Caris Life Sciences ® announced today that Tampa General Hospital Cancer Institute (TGH Cancer Institute) has joined Caris’ Precision Oncology Alliance™ (POA).

March 1, 2022
·
8 min read
Business

Cerevel Therapeutics Provides Update on Pipeline Progress along with Fourth Quarter and Full Year 2021 Financial Results

Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today reported financial results for the fourth quarter and full year ended December 31, 2021 and provided key business updates.

March 1, 2022
·
14 min read
Drug Development

Phase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints

Phase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints.

March 1, 2022
·
10 min read
Genetown

iTeos to Present at the Cowen 42nd Annual Health Care Conference

iTeos Therapeutics, Inc. today announced that Michel Detheux, Ph.D., President and Chief Executive Officer, will present at the Cowen 42nd Annual Health Care Conference on Tuesday, March 8, 2022 at 12:50 p.m. ET.

March 1, 2022
·
2 min read